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• 12 bovine isolates out of an Irish collection were sequenced and sequencing data 
revealed that sequence types (ST) associated with cattle were not associated with 
epidemic ST or virulent clonal complexes 
• Every sequenced isolate showed mutations within gyrA, conferring resistance to 
fluoroquinolones 
• These isolates also show hetereogeneity in biofilm formation 







Antimicrobial resistance reported in bacteria of animal origin is considered a major challenge 
to veterinary public health. In this study, the genotypic and phenotypic characterisation of 
twelve Escherichia coli isolates of bovine origin is reported. 
Twelve bacterial isolates of animal origin were selected from a previous study based on their 
multidrug resistant (MDR) profile.  Efflux pump activity was measured using ethidium 
bromide (EtBr) and the biofilm forming ability of the individual strains was assessed using a 
number of phenotypic assays. 
All isolates were resistant to tetracyclines and a number of the isolates expressed resistance to 
fluoroquinolones which was also confirmed in silico by the presence of a number of these 
resistance markers. Amino acid substitutions in the quinolone resistance-determining regions 
were identified in all isolates and the presence of several siderophores were also noted. WGS 
data showed different STs that were not associated with epidemic STs or virulent clonal 
complexes. 
Seven isolates formed biofilms in minimal media with some isolates showing better adaptation 
at 25 °C while others at 37°C. The capacity to efflux EtBr was found to be high in 4 isolates 









The pathogenicity of three selected isolates was assessed in zebrafish embryo infection models, 
revealing isolates CFS0355 and CFS0356 as highly pathogenic. 
These results highlight the application of NGS technologies combined with phenotypic assays 
in providing a better understanding of E. coli of bovine origin and their adaptation to this niche 
environment. 




Intensive use of antimicrobial compounds in agricultural and veterinary settings has been 
documented to contribute to the emergence of resistance phenotypes among bacteria of animal 
origin (Economou and Gousia, 2015; Wepking et al., 2017). Even in the absence of direct 
antimicrobial pressure, the spread of resistance determinants continues to occur being mainly 
associated with horizontal exchange of mobile genetic elements (MGE) among different 
bacterial species in these niche environments (Sjölund et al., 2008; Poeta et al., 2009; Frye et 
al., 2011). The emergence of antimicrobial resistance in food-producing animals is of particular 
concern as these zoonotic bacteria pose a risk to human health via the food chain (Hammerum 
and Heuer, 2009). Among the pathogens that are of importance to human health, Salmonella 
species and E. coli are of relevance due to their propensity to contribute to the dissemination 
of antimicrobial resistance markers (Laufer et al., 2014; Dahms et al., 2015; Robertson et al., 
2016).  
Bovine animals are a major reservoir for E. coli, in particular, the Shiga-toxin producing E. 
coli (STEC) O157:H7 (Ferens and Hovde, 2011; Bono et al., 2012). Understanding how these 
and other serotypes of E. coli adapt to the host environment, bovine and human alike, and what 
drives the acquisition of antimicrobial resistance is of primary concern. By extending our 
knowledge of these processes it may be possible to devise strategies to reduce the spread of 
antimicrobial resistance via the food chain. Moreover, the transmission of antimicrobial 
resistance genes between pathogenic and commensal bacteria poses a threat that can no longer 
be ignored (Szmolka and Nagy, 2013; Kheiri and Akhtari, 2016; Samei et al., 2016).  
The paucity of new antimicrobial compounds being delivered from drug development pipelines 
is an important public health challenge. Thus, alternative strategies must be considered and 









approaches have been applied to reverse the dissemination of these markers. However, the 
successful adoption of these approaches has had only limited success to date (Lomovskaya and 
Bostian, 2006).  
In this work, a subset of E. coli bovine isolates from a collection of Irish E. coli of animal origin 
previously described by Karczmarczyk et al., 2011 were selected for further characterisation. 
These isolates were assayed for biofilm and pellicle formation, antibiotic resistance, and efflux 
pump activity in conjunction with whole genome sequencing data.   
Materials and Methods- 
Bacterial study isolates and reagents  
Twelve E. coli veterinary clinical isolates of bovine origin obtained in 2007 from the UCD 
Veterinary Hospital (Karczmarczyk et al., 2011), in Dublin were further investigated (Table 
S1). E. coli ATCC™ 25922 and Salmonella enterica subsp. enterica serovar Typhimurium 
ATCC™14028 were included as reference strains in all phenotypic assays. 
Mueller-Hinton (MH) broth and MH agar, Luria-Bertani (LB) broth, phosphate buffered saline 
(PBS) and all powder-based antimicrobial compounds, apart from moxifloxacin, were obtained 
from Sigma-Aldrich (Darmstadt, Germany). Moxifloxacin was purchased from Santa Cruz 
Biotechnology (Dallas, TX, USA). All the diffusion disk antibiotics were purchased from 
Oxoid (Thermo Scientific, Waltham, MA, USA). 
 
Antibiotic susceptibility test (AST)  
Susceptibility of each isolate to a panel of antimicrobial compounds was determined by disk 
diffusion according to the Clinical and Laboratory Standards Institute (CLSI) protocols. 
Bacterial overnight cultures were diluted in sterile 0.85% NaCl suspension medium 
(bioMérieux, Marcy-l’Étoile, France) to 0.5 McFarland standard and spread using a cotton 
swab. Disks containing amikacin (AK – 30 μg), aztreonam (ATM – 30 μg), cefepime (FEP – 
30 μg), cefotaxime (CTX – 5 μg), ceftazidime (CAZ – 10 μg), chloramphenicol (C – 30 μg), 
ciprofloxacin (CIP – 5 μg), doripenem (DOR – 10 μg), doxycycline (DO – 30 μg), ertapenem 
(ETP – 10 μg), gentamicin (CN – 10 μg), imipenem (IPM – 10 μg), levofloxacin (LEV – 5 μg), 
meropenem (MEM – 10 μg), minocycline (MH – 30 μg), moxifloxacin (MXF – 5 μg), nalidixic 
acid (NA – 30 μg), norfloxacin (NOR – 10 μg), tetracycline (TET – 30 μg), ticarcillin (TIC – 








sulfamethoxazole (SXT – 25 μg) were included. Inoculated plates, containing the disks above 
were incubated at 37°C and zone inhibition measured after 16‒18 h. Susceptibility or resistance 
was determined by CLSI guidelines, M100-S23 (CLSI, 2018). In the case of moxifloxacin and 
tigecycline the breakpoints used were those from the European Committee on Antimicrobial 
Susceptibility Testing - EUCAST (2016) (http://www.eucast.org/clinical_breakpoints/). This 
assay was performed in triplicate for each clinical isolate.  
 
Genomic and plasmid DNA purification  
Genomic DNA was purified from overnight cultures using the UltraClean® Microbial DNA 
Isolation Kit (MoBio Laboratories, Carlsbad, CA) according to manufacturer’s instructions. 
Large plasmid purification was carried out using S1-nuclease (Promega, Madison, WI) 
followed by pulsed-field gel electrophoresis (PFGE). E. coli 39R 861 and E. coli V517 were 
included as controls. Briefly, the procedure included a lysis step for the bacterial cells, 
previously embedded in agarose plugs followed by digestion with 8 U S1-nuclease at 37°C for 
45 min. Finally, each plasmid sample was then resolved by PFGE in a Chef-Mapper® XA 
System (Bio-Rad, Hercules, CA) at 14°C, with a switch time setting between 1 and 12 s, at 6 
V/cm on a 120° angle in 0.5X TBE buffer for 18 h in a 0.8% [w/v] agarose gel and stained with 
SYBR green. The approximate molecular mass of plasmids was determined by comparing band 
molecular sizes with the two control isolates and by using Salmonella Braenderup H9812 
previously digested with XbaI (Wang et al., 2013). 
 
Bacterial whole genome sequencing  
Genomic libraries were prepared using the NEBNext Ultra II (New England Biolabs, Ipswich, 
MA) for each of the twelve E. coli sequenced on the Illumina MiSeq platform (Illumina, San 
Diego, CA). The quality of the reads was assessed using FastQC (version 0.11.5). Error 
correction was performed using BFC (version r181). A relaxed quality trim was performed 
using Trimmomatic (version 0.36) before de novo assembly using SPAdes (version 3.9.1). The 
quality of the subsequent assemblies was assessed using Bandage (version 0.8.1) and QUAST 
(version 5.2). Prokka 1.13.3 was used to annotate the genomes for use in Roary (3.11.2) to 










Antimicrobial resistance-encoding genes were identified using Resfinder 3.2 (accessed 26-11-
2019) (https://cge.cbs.dtu.dk/services/ResFinder/). Plasmid replicon typing was performed 
using PlasmidFinder 1.3 (https://cge.cbs.dtu.dk//services/PlasmidFinder/). Antibacterial 
biocide and metal resistance genes were extracted by querying the BacMet 1.1 database 
(http://bacmet.biomedicine.gu.se) and virulence genes were identified by comparison with the 
virulence factor database (VFDB) (http://www.mgc.ac.cn/VFs/). Sequences from these 
databases were identified within the genomes of all isolates using BLAST+ (version 2.5.0) and 
Biopython (version 1.68). Multilocus sequence typing (MLST) and serotyping was performed 
in silico using the SRST2 tool. Phylogrouping was performed using ClermonTyper (Beghain 
et al., 2018).  
Raw sequencing data is deposited in the SRA under study accession PRJEB33643 
(Supplementary Table 1). 
Amino acid substitutions in the quinolone resistance-determining regions (QRDR), global 
regulatory-encoding genes, RND efflux pump acrAB-tolC, outer membrane proteins, biofilm, 
curli and cellulose genes were identified by comparing the genes against the reference strain 
E. coli K-12 MG1655 
 
Minimum inhibitory concentration (MIC) and minimum bactericidal concentration 
(MBC)  
MIC and MBC values for cefotaxime (CTX), chloramphenicol (CHL), ciprofloxacin (CIP), 
gentamicin (CN), imipenem (IMP), kanamycin (KM), moxifloxacin (MXF), nalidixic acid 
(NAL), and tetracycline (TET) were measured by two-fold broth microdilution in a 96-well 
microtiter plates as described previously (Anes et al., 2017).  
 
Biofilm formation assay, Congo red, calcofluor staining and pellicle formation 
Biofilm formation was examined under defined growth parameters. M9 minimal media 
(containing NH4Cl [1.9 mM], Na2HPO4 [42.3 mM], KH2PO4 [22 mM], NaCl [8.56 mM], 
MgSO4 [2 mM], CaCl2 [0.1 mM], and glucose 0.1% [w/v] was used to enable an assessment of 
biofilm formation and cultures were incubated at 25 and 37 °C respectively at 24 and 48 hours.  
Initially, overnight cultures were adjusted to OD600 nm 0.3 with fresh media, and 200 µL of this 









incubated statically for 24 and 48 hours at temperatures of 25 and 37°C respectively. 
Salmonella Typhimurium ATCC™14028 was used as a positive control for biofilm formation. 
A crystal violet assay was carried out to quantify the mass of biofilm formed as before 
(Stepanović et al., 2007). 
The expression of curli fimbriae was assessed by examining the colony morphology of the E. 
coli isolates on Congo red agar. Calcofluor agar plates were used to assess the ability of each 
isolate to produce cellulose (Anes et al., 2017). The Congo red agar and the calcofluor plates 
were spotted with 3 µL aliquots of overnight bacterial culture grown in MH broth and incubated 
for 72 h at 25 and 37°C after which colony morphology was inspected. The calcofluor plates 
were visualised under a 366-nm UV light source in order to detect the binding of the fluorescent 
dye to any cellulose produced. Salmonella Typhimurium ATCC™14028 was included as a 
control and both assays were carried out in triplicate for each isolate. 
For pellicle formation, 50 µL from an overnight culture in MH broth was used to inoculate 5 
mL MH broth, which was then incubated statically for 96 h at 25 and 37°C after which it was 
then inspected for the formation of a pellicle at the air-broth interface (Zogaj et al., 2001). This 
assay was repeated on two independent occasions and results were registered as present or 
absent. 
 
Assessment of efflux pump activity by fluorimetry using ethidium bromide (EtBr) 
Ethidium bromide (EtBr) was used as a marker to assess the efflux capacity of each clinical 
isolates as previously described (Anes et al., 2017). In brief, bacterial isolates were grown to 
mid-log10 phase and washed twice with PBS then the OD600 nm was adjusted to 0.6. Cells were 
then subsequently incubated in PBS in the presence of EtBr (50 µM) and 100 µM of carbonyl 
cyanide m-chlorophenyl hydrazone (CCCP) at 25 °C for 1 h. Afterwards, the cells were 
centrifuged for 16,000 x g for 3 min. and the cells resuspended in i) PBS; ii) PBS with 50 mM 
glucose and iii) PBS with 100 µM CCCP. Aliquots of 0.1 ml were transferred into a 96-well 
microtitre plate and EtBr fluorescence was measured in a Fluoroskan Ascent FL (Thermo 
Scientific, Waltham, MA) with excitation and emission wavelengths of 518- and 606-nm, 
respectively. Fluorescence emissions were acquired in cycles of 60 seconds, for a duration of 
50 min. at 37 °C. Each assay was performed in triplicate. The efflux of Etbr was presented as 
relative fluorescence which was obtained by comparing the fluorescence observed for the 









exposed to conditions of minimum efflux (in the absence of glucose and in the presence of 
CCCP). 
 
Zebrafish ethics statement 
Experiments were carried out until 72 hours post infection (hpi) and at the end of the 
experiments, embryos that were alive were euthanized with an overdose of 4 g/L buffered 
tricaine. Since pain sensitivity has not developed at these earlier stages (5 days post 
fertilization, dpf), this is not regarded as a painful technique. The maximum age reached by the 
embryos during experimentation was 120 hpf (72 hpi) for which no license is required from 
the Swiss cantonal veterinary office. This research was conducted with approval (NO 
216/2012) from the Veterinary Office, Public Health Department, Canton of Zurich 
(Switzerland) allowing experiments with zebrafish embryos and larvae. The methods applied 
were carried out following approved guidelines. 
 
Zebrafish lines and husbandry 
Zebrafish (Danio rerio) strains used in this study were wik lines. Adult fish were kept at a 14/10 
hours light/dark cycle at a pH of 7.5 and 27°C. Eggs were obtained from natural spawning 
between adult fish which were set up pairwise in individual breeding tanks. Embryos were 
raised in petri dishes containing E3 medium (5 mM NaCl, 0.17 mM KCl, 0.33 mM CaCl2, 0.33 
mM MgSO4) supplemented with 0.3 µg/mLmethylene blue at 28°C. From 24 hpf, 0.003% 1-
phenyl-2-thiourea (PTU) was added to prevent melanin synthesis. Staging of embryos was 
performed as previously described (Kimmel et al., 1995).  
 
Microinjection experiments 
Injections were performed using borosilicate glass microcapillary injection needles (Science 
Products, 1210332, 1 mm O.D. x 0.78 mm I.D.) and a PV830 Pneumatic PicoPump (World 
Precision Instruments). Thirty-six-hour-post-fertilization (hpf) embryos were manually 
dechorionated and anesthetized with 200 mg/L buffered tricaine (Sigma, MS-222) prior to 
injections. Subsequently embryos were aligned on an agar plate and injected with 100 CFU 
(range 86 - 128 CFU) in 1-2 nL volume of a bacterial suspension in DPBS directly into the 









by injecting a droplet into mineral oil and measuring its approx. diameter over a micrometer 
scale bar. The number of CFUs injected was determined by injection of bacterial suspension 
into a DPBS droplet on an agar plate. Following injections infected embryos were allowed to 
recover in a petri dish with fresh E3 medium for 15 min. To follow infection kinetics and for 
survival assays, embryos were transferred into 24-well plates (one embryo per well) in 1 mL 
E3 medium per well, incubated at 28°C and observed for signs of disease and survival under a 
stereomicroscope twice a day. For survival assays after infection, the number of dead larvae 
was determined visually based on the absence of a heartbeat. Kaplan Meier survival analysis 
was done with GraphPad Prism 7 (GraphPad Software, United States). Experiments were 
performed at least three times, unless stated otherwise. 
 
Results 
Phenotypic characterisation of the bacterial isolates 
A subset of twelve E. coli isolates of bovine origin, from a clinical collection of twenty animal 
isolates obtained from the UCD Veterinary Hospital in Dublin in 2007 (Karczmarczyk et al., 
2011) were further characterised. Their MDR profile was previously determined for some of 
the antimicrobial compounds selected (Karczmarczyk et al., 2011). In this present study, the 
antimicrobial drug panel was extended to 21 compounds with representatives of each 
antimicrobial class. The results presented in Figure 1 shows the resistance profiles of these 
twelve E. coli. The isolates clustered based on their resistance profile and all were resistant to 
quinolones, fluoroquinolones, and tetracyclines. Based on the antimicrobial resistance profile 
and previously published data E. coli CFS0344, CF0345, CFS0347 to CFS051, CFS0354-
CFS0356, CFS0359 and CFS0360 were selected for further genotypic and phenotypic studies.  
The antimicrobial resistance profile of the selected isolates was further confirmed by broth 
microdilution with several antimicrobial agents representative of different classes. Minimum 
inhibitory concentration (MIC) values were determined (Table 1) and the results showed that 
for the majority of the isolates, their resistance profile matched the results obtained by disk 
diffusion. In the case of E. coli CF0344, CFS0345 and CFS0350 an imipenem resistance 
phenotype was noted, for the first two of these and an intermediate phenotype for the remaining 
isolate, a pattern that was not captured by disk diffusion assay. All isolates determined to be 









(MDR). Minimum bactericidal concentration (MBC) values (Table S2) were similar to those 
obtained for MIC measurements.  
Determination of the efflux pump activity by fluorimetry for E. coli cultured from bovine 
animals 
The ability of these bacterial isolates to efflux chemical compounds from the cell was assessed 
by fluorimetry. In order to determine the functional efflux activity of the bacterial isolates, cells 
were pre-loaded with ethidium bromide and fluorescence measured over a period of 50 
minutes. EtBr, when bound to cellular components, fluoresces with more intensity and thus 
cells with active efflux pumps will appear less fluorescent due to dye extrusion. To explore 
another feature of the efflux pump activity, previously loaded bacterial cells were incubated in 
the presence of glucose and/or the proton motive force (PMF) uncoupler CCCP. Figure 2 
shows the differences observed between the isolates studied. 
In the presence of PBS alone all isolates exhibited approximately the same efflux capacity. The 
presence of CCCP prevented efflux of EtBr, leading to minor decreases in the intensity of the 
fluorescence detected with similar effects for all isolates. When glucose was added to these 
cells (50 mM final concentration), all were able to extrude EtBr at an increased rate. In the 
presence of glucose, E. coli CFS0354, CFS0355, CFS0356 and CFS0359 had reduced efflux 
activity compared to the other isolates.  
 
Biofilm formation and associated morphotypes 
The potential to form biofilms, confers on bacteria an extra layer of protection against the 
external environment, including effects of antimicrobial agents and other environmental 
stresses. All study isolates were tested for their ability to form biofilms under stressful 
conditions at 25 °C (commonly associated with environmental temperatures) and at 37 °C 
(associated with human/animal body temperature) using the crystal violet method. The results 
of these assays are presented in Figure 3. 
Results indicated that half of the isolates (E. coli CFS0345, CFS0351, CFS0354, CFS0359 and 
CFS360) were unable to form robust biofilms under the in vitro conditions tested. E. coli 
CFS0347, CFS0348 and CFS0349 produced stronger biofilms at 25 °C. In contrast, E. coli 









The isolates were also assessed for their ability to form a pellicle at the air-liquid interface 
(supplementary Table S3 and Table S4). Only E. coli CFS0349 was capable of forming a 
pellicle at 25 °C. At 37 °C five E. coli isolates (including CFS0350, CFS0351, CFS0354, 
CFS0355 and CFS0356) could form air-liquid interface pellicles.  
The expression of curli fimbriae and the production of cellulose, involved in the formation of 
biofilms was measured using agar plates incubated at 25- and 37-°C and containing Congo red 
and calcofluor dyes that stain these corresponding features. The results are shown in 
supplementary Table S3 and Table S4 and the associated morphotypes described in each case 
by reference to Salmonella enterica serovar Typhimurium ATCC™14028, an isolate 
previously reported to produce a RDAR morphotype.  
At 25 °C only 3 E. coli (CFS0347, CFS0348 and CFS0349) expressed the RDAR morphotype. 
Two of the collection isolates E. coli CFS0355 and CFS0356 elaborated a smooth and white 
(SAW) morphotype which is characterised by the absence of curli fimbriae and lacking 
cellulose (Zogaj et al., 2001). The remaining isolates produced an intermediate morphotype 
that in this case, is defined as red and smooth (RAS). Two of the study isolates, E. coli CFS0347 
and CFS0348 were determined to produce cellulose. The remaining isolates were considered 
negative for the expression of this phenotype. The results recorded at 37 °C did not show any 
typical Congo red morphotypes that would suggest the expression of curli fimbriae. The 
majority of the isolates produced a SAW morphotype. The expression of cellulose was lacking 
in all of the isolates when grown at 37 °C.  
 
Characterisation of the genomes of the selected E. coli isolates 
Genomic DNA was purified and sequenced using the Illumina Miseq platform. An overview 
of the assembly metrics is presented in supplementary Table S5 and a visualisation of the 
pangenome in supplementary Figure S1.  
Multi-locus sequence types (MLST) were inferred from the genomic sequences of 7 
housekeeping genes (adk, fumC, gyrB, icd, mdh, purA, recA) according to the published MLST 
scheme (Wirth et al., 2006). Sequence type results and genomic serotyping are shown in Table 
2. The majority of the isolates belong to the sequence type ST10 (n=4). E. coli CFS0355 and 
CFS0356 belonged to ST540, whereas the E. coli isolates CFS0359 and CFS360 were found 
to be ST744 types. Two other E. coli CFS0347 and CFS0349 were identified as ST90 and ST88 









According to the ClermonTyper scheme, the majority of the isolates were phylogroup A (Table 
2). CFS0347, CFS0349, and CFS0350 were phylogroup C while CFS0348 is the lone 
phylogroup D isolate (Table 2). 
Genomic-based serotyping revealed that serotype O89:H9 was common among these isolates 
of types, ST10 and ST744. Serotype O9:H30 was associated with the isolates of the sequence 
type, ST540. The remaining isolates presented diverse serotypes (see Table 2).  
Acquired antimicrobial resistant genotypes were extracted from these genome sequences and 
organised in classes has shown in Table 2. More detailed information describing the 
corresponding antimicrobial resistance-encoding genes are included in supplementary Table 
S6.  
Results show that all bacterial isolates were positive for genes that conferred resistance to β -
lactam antibiotics. The blaTEM gene was identified in 11 of the 12 isolates. Only one, E. coli 
CFS0347, contained a different β -lactam resistance gene, blaCMY. Genes conferring resistance 
to different members of the aminoglycoside class were found in all isolates and were reflected 
by their antibiotic resistance phenotypes obtained by AST (Table S6 and Figure 1).  
Resistance to tetracycline observed among these isolates was further supported by the presence 
of the genes tet(34), tet(A), tet(B) and tet(C) identified among all isolates. Chloramphenicol 
resistance was also confirmed by the presence of phenicol resistance-encoding genes in 10 of 
the 12 isolates. Where isolates were previously determined to be susceptible to this drug, as in 
the case of E. coli CFS0355 and CFS0356, no resistance markers were detected. No acquired 
resistance gene(s) were identified for fluoroquinolones and carbapenems. The presence of 
quaternary ammonium resistance-encoding gene qacEΔ1 was confirmed in 10 of the 12 E. coli 
isolates with the exception of the isolates E. coli CFS0351 and CFS0354.  
Isolates containing multiple plasmids, as determined by S1-nuclease PFGE profiling included 
E. coli CFS0355 and CFS0356 both belonging to the ST540 complex. The plasmid 
incompatibility types identified in these isolates included IncF, IncH and IncX types. Similarly, 
E. coli CFS0359 also was positive for three Inc types, denoted as IncN, IncQ and IncR (Table 
2).  
Virulence factor-encoding genes were extracted using the VFDB database as a reference. Data 
included in Table 2 shows the presence of the siderophores enterobactin and aerobactin in all 
the isolates. Four E. coli, denoted as CFS0349, CFS0355, CFS0356, CFS0359 and CFS0360 









contained the yersiniabactin operon. Interestingly, E. coli CFS0348 also contained the hemin 
utilization operon (chu genes).  
The type I fimbriae operon (fim) was detected in 10 out of 12 isolates, with the E. coli isolates 
CFS0355 and CFS0356 indicating the presence of only fimH. P fimbriae-encoding genes (pap) 
were only identified in E. coli CFS00349, CFS0350 and CFS0351. Other fimbriae types such 
as fae, f17d and afa were also identified in the genome sequences of several isolates (Table 
S6). 
Other relevant virulence genes such as the tsh genes, encoding for the temperature-sensitive 
hemagglutinin, were identified in E. coli CFS0355 and CFS0356. The toxin gene astA encoding 
the enteroaggregative heat-stable toxin 1 (EAST1) was also found in 58% of the isolates (n=7). 
Type II general secretory protein pathway genes (gsp) and type III secretion system effectors 
were identified in the genomes of E. coli CFS0347, CFS0348, CFS0349 and CFS0350.  
No major differences in the resistance genotypes to heavy metals was noted among the isolate 
collection. Interestingly, the copper homeostasis and silver resistance island (CHASRI) that 
confers resistance to copper under aerobic and anaerobic growth conditions, was identified in 
E. coli CFS0355 and CFS0356.  
Amino acid substitutions in the GyrA subunit of DNA gyrase were identified in all E. coli study 
isolates. These were detected within the quinolone-resistance determining region (QRDR) at 
residue positions 83 and 87. These latter substitutions were previously reported as contributing 
to the emergence of resistance to quinolones and fluoroquinolones (Fu et al., 2013). E. coli 
CFS0348 also presented an additional substitution at position 678, and the role (if any) of this 
change is unknown. A single amino acid substitution was identified in GyrB in four isolates 
(E. coli CFS0348, CFS0349, CFS0359 and CFS0360) in each case occurred at different 
positions. The amino acid sequences of ParC and ParE also showed several substitutions. A 
complete summary of all amino acid substitutions identified can be seen in Table S7. 
As a diverse resistance phenotype was identified in the study isolates, it is reasonable to 
question the contribution of efflux transporter systems. Genomic data was assessed for the 
presence of mutations/amino acid substitutions in a selected number of these specific genes. 
Amino acid (AA) substitutions were identified in different positions for AcrB and TolC in E. 
coli CFS0348 and CFS0349. Similarly, AA substitutions in the global regulators MarR and 
MarB were also noted in E. coli CFS0347, CFS0348, CFS0349, CFS0350, CFS0355 and 









192 for E. coli CFS0350. Two AA substitutions were recorded in E. coli CFS0348 in the 
regulator SoxR. Several other amino acid substitutions were identified in the membrane porins, 
OmpC and OmpF in all the isolates.  
In addition, several AA modifications were also identified in the cellulose-encoding operon 
bcsABCZ among the E. coli isolates CFS0347, CFS0348, CFS0349 and CFS0350 where all of 
the corresponding genes possessed modifications. The amino acid sequence of BcsZ was found 
to be truncated in those isolates belonging to the sequence types, ST10 and ST744. Curli 
fimbriae-encoding proteins CsgA and CsgB were also found to contain amino acid 
substitutions that in this case were associated with only one E. coli isolate, CFS0348. Other 
genes within this operon, including csgC and csgD contained AA substitutions in E. coli 
CFS0347, CFS0348, CFS0349, CFS0350, CFS0355 and CFS0356 (Table S7).  
 
Pathogenicity of E. coli isolates in a zebrafish model  
Three of the isolates (E. coli CFS0348, CFS0355 and CFS0356) were selected to test their 
ability to infect zebrafish based on their genotypes and phenotypes. Survival curves were 
generated for zebrafish embryos (n = 30 per E. coli isolate) infected (100 CFU per embryo) 
with E. coli and monitored over 3 days. Zebrafish embryos rapidly succumbed to the infection 
with E. coli ST540 CFS0355 and CFS0356 strains, while those infected with E. coli CFS0348 
died later. Survival curves and trends were significantly different (log10-rank test p < 0.0001) 
in Figure 4. 
 
Discussion- 
The rapid rise in reported antimicrobial resistance is forcing a paradigm shift in how these 
drugs are applied in various settings. As resistance spreads at a pace that is coupled with a lack 
of any development of new antimicrobial agents, the need to find workable solutions to this 
public health challenge has now become urgent. In this paper, a collection of E. coli of bovine 
origin obtained from the UCD Veterinary Hospital were further studied. All were re-tested for 
their susceptibility to a panel of compounds and subjected to a number of more detailed 
phenotypic and genotypic investigations. Based on the MLST data obtained, none of the 
isolates were associated with epidemic or virulent clonal complexes. Extended-spectrum 
AmpC β-lactamases have been linked to ST23 (Crémet et al., 2010) which highlights how 









serotyping revealed that serotype O89:H9 was common among these isolates of types, ST10 
and ST744. Serotype O9:H30 was associated with the isolates of the sequence type, ST540. 
Nonetheless a diverse phenotypic picture was observed within the study collection. 
All of the selected isolates were found to be resistant to fluoroquinolone and tetracycline 
compounds. When extracted from the whole genome sequence reads, acquired genotypes 
identified, for the most part, showed that the majority of these isolates possessed the 
corresponding resistance genes, originally inferred from the phenotypes determined by AST. 
Resistance to imipenem was not associated with any particular acquired resistance gene. While 
members of Enterobacteriaceae are intrinsically resistant to macrolides, the presence of the 
mph(B) gene in E. coli CFS0355 and CFS0356 is notable as previous studies suggest E. coli 
may serve as reservoirs for macrolide resistance genes (Nguyen et al., 2009). The presence of 
CHASRI in CFS0355 and CFS0356 may be due to the use of copper as an animal feed 
supplement and could be responsible for the selective acquisition of the heavy metal resistance 
genes identified here (Staehlin et al., 2016).  
Efflux pump activity is an important intrinsic characteristic of bacteria, which aids bacterial 
adaptation in an environmental niche and this feature is known to contribute to antimicrobial 
resistance in some cases (Nikaido and Takatsuka, 2009). In Gram-negative bacteria the best-
known efflux system is represented by members of the resistance nodulation-cell division 
(RND) family. This efflux family, and in particular AcrAB-TolC, has been associated with the 
extrusion of acriflavine, ethidium bromide, fluoroquinolones, tetracyclines, tigecyclines, and 
many other compounds from the bacterial cytoplasm (Anes et al., 2015). AcrAB-TolC was also 
shown to play a role in virulence in several pathogenic bacteria (Blair and Piddock, 2009; Pérez 
et al., 2012; Tsai et al., 2015). E. coli CFS0345 CFS0348, CFS0350 and CFS0351 exhibited 
an active efflux mechanism when compared with the other isolates. This activity could be 
attributed to the amino acid substitutions identified at different positions in AcrB and TolC 
sequences in E. coli CFS0348 and CFS0349 or AA substitutions in the global regulators 
including MarR and MarB in E. coli CFS0348, CFS0349 and CFS0350.  
Among the virulence genes identified, iron scavenging proteins (siderophores) are of 
importance. Apart from their obvious biological function wherein they participate in 
scavenging iron, a co-factor essential for several cellular processes, these proteins are 
considered to be important to facilitate pathogen survival in the host (Ratledge and Dover, 
2000; Snyder et al., 2004; Hagan et al., 2010).  Salmochelin (present in E. coli CFS0349, 









known to be associated with invasive E. coli serotypes (Henderson et al., 2009). Interestingly, 
yersiniabactin has been identified in other ST88 previously (Huja et al., 2015).  The presence 
of these siderophore genes highlight the potential pathogenicity of these E. coli from bovine 
origins. The temperature-sensitive hemagglutinin (tsh) was identified in E. coli CFS350, 
CFS0355, and CFS0356 and has previously been reported in bovine E. coli (Kassé et al., 2016). 
ST540 CFS0355 and CFS0356 showed higher mortality when compared to ST6901 CFS0348, 
however all strains were pathogenic in an in vivo zebrafish embryo infection model. The 
presence of the salmochelin siderophores and tsh in CFS0355 and CFS0356 may contribute to 
increased virulence in zebrafish embryos and ST540 E. coli have been previously isolated from 
urinary tract infections in Denmark (Hertz et al., 2016).   
Common incompatibility types identified from the genome sequences included IncF and Col 
types, both of which are frequently detected among Gram-negative bacteria (Carattoli, 2009). 
IncHI2 plasmids have been implicated for the spread of heavy metal resistance islands in E. 
coli associated with food producing animals (Fang et al., 2016) and the IncHI2 plasmid 
replicons were detected in E. coli CFS0355 and CFS0356. 
Five of the E. coli (isolates CFS0345, CFS0351, CFS0354, CFS0359 and CFS360) were unable 
to form biofilms under the laboratory-induced in vitro conditions used. Of those isolates 
capable of forming biofilms (n=7), three appeared to form robust biofilms when cultured at 37 
°C, whereas the remaining four isolates formed better biofilms at the environment temperature 
(25 °C). The RDAR morphotype (indicating the expression of fimbriae and cellulose 
production) was observed only at 25 °C in 3 E. coli (CFS0347, CFS0348 and CFS0349). 
Several modifications identified within related genes were detected and these included the 
cellulose biosynthetic-encoding operon bcsABCZ, in particular, in E. coli CFS0347, CFS0348, 
CFS0349 and CFS0350. E. coli CFS0348 contained multiple substitutions within the 
corresponding genes encoding curli proteins CsgA and CsgB. Of the remaining proteins of the 
curli operon, amino acid substitutions in CsgC and CsgD were present in CFS0347, CFS0348, 
and CFS0350.  
 
Conclusions- 
The collection of isolates chosen in this study were from bovine origins.  All of the isolates 
expressed an MDR phenotype and notably, every isolate had mutations within gyrA resulting 









mechanisms including blaTEM, blaCMY, and aminoglycoside genes together with accumulation 
of point mutations in the QRDR.  In addition to genetic changes, E. coli CFS0345, CFS0348, 
CFS0350, and CFS0351 showed increased efflux pump activities resulting in diverse MDR 
phenotypes.  Interestingly no acquired resistance mechanisms against FQ nor carbapenems 
were detected.  A number of different plasmid replicon types were identified, including IncFIB, 
Col and IncHI2.  These plasmids are important vectors for the of horizontal transfer of 
antimicrobial resistance, heavy metal resistance, and virulence genes such as siderophores. 
WGS of twelve of the isolates revealed diverse STs that were not associated with epidemic STs 
or virulent clonal complexes.  Several serotypes were identified in the sequenced E. coli of 
bovine origin including O8:H9, O8:H19, O9:H12, O9:H30, O11:H15, and O89:H9.  In addition 
to ST diversity, these isolates expressed phenotypic heterogeneity in biofilm formation.  The 
differences in biofilm formation at host or environmental temperatures would suggest potential 
niche adaptation for some of the isolates. Zebrafish infection studies with 3 of the isolates 
revealed that E. coli of bovine origin are pathogenic. The virulence of E. coli CFS0355 and 
CFS0356 (most virulent isolates tested) may be linked with the presence of several encoding 
siderophores. 
These results show that overall, the genomic characterisation reflects the phenomic data.  In 
some cases, however accurate AMR prediction from genomic information can be challenging. 
These results underly the importance of using NGS technologies in combination with 
traditional phenotypic methods to corroborate genomic data and to assay for genotypes and 
phenotypes of bovine E. coli suggestive of its potential for niche adaptation. 
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Figure 1. Dendrogram constructed using BioNumerics™ software (ver 7.5, Applied Maths, 
Sint-Martens-Latem, Belgium), showing the antibiotic resistance profiles detected following 
disk diffusion assays. The dendrogram shows the clustering based on these resistance 
profiles. Red coloured cells indicate – resistant phenotypes; yellow – intermediate resistance 
and green – susceptible phenotypes. Breakpoints were interpreted according to CLSI 
guidelines 2018 with the following exception: Tigecycline, Moxifloxacin - the breakpoints 
used in these cases were those published in the EUCAST guidelines 2016. The following 
abbreviations apply to the listing of compounds within individual drug classes: TIM-
Ticarcillin-clavulanic acid; FEP-Cefepime; ATM-Aztreonam; AK-Amikacin; CN-
Gentamicin; DO-Doxycycline; MH-Minocycline; TE-Tetracycline; TGC-Tigecycline; CIP-
Ciprofloxacin; LEV-Levofloxacin; MXF-Moxifloxacin; NA-Nalidixic Acid; NOR-
Norfloxacin; DOR-Doripenem; ETP-Ertapenem; IPM-Imipenem; MEM-Meropenem; C-











Figure 2. Determination of efflux activity for all 12 E. coli by a semi-automated fluorometric 
method. Isolates were saturated with 50 µM ethidium bromide and efflux measured by 
fluorimetry at 37 °C for 50 minutes. Arrowheads indicate the time points at which either 











Figure 3.  Biofilm biomass quantification for E. coli isolates of bovine origin. Biofilms were 
grown statically in M9 minimal media for 24- and 48-hours at 25- and 37-°C. The biomass 
formed was subsequently detected by crystal violet staining. Optical densities of 0.46 and 











Figure 4. Zebrafish model. Survival curves were generated for zebrafish embryos (n = 30 
per E. coli strain) infected (100 CFU per embryo) with E. coli strains and monitored over 3 
days. Zebrafish embryos rapidly succumbed to E. coli CFS0355 and CFS0356, while those 
infected with the E. coli CFS0348 died later. Survival curves and trends were significantly 
different (log10-rank test p < 0.0001). 
 
 
Table 1. A table showing the minimal inhibitory concentrations (MIC) obtained for E. coli 
bovine study isolates, tested against a panel of 10 antimicrobial compounds. AMP - 
ampicillin; CHL – chloramphenicol; CIP - ciprofloxacin; CN - gentamicin; CTX - 
cefotaxime; IMP - imipenem; KM - kanamycin; MXF - moxifloxacin; NAL - nalidixic acid; 




Amp CTX CN Km IMP NAL CIP MXF TET CHL 
CFS0344 >512 1 32 >512 4 >512 16 16 256 256 
CFS0345 >512 1 32 >512 4 >512 16 16 256 512 
CFS0347 >512 8 16 32 1 >512 8 8 512 128 
CFS0348 >512 1 16 >512 1 >512 8 8 512 512 
CFS0349 >512 2 1 2 1 >512 4 4 64 512 









CFS0351 >512 1 1 2 1 >512 16 8 512 512 
CFS0354 >512 1 1 1 1 >512 8 8 512 256 
CFS0355 >512 1 16 1 1 >512 16 16 256 4 
CFS0356 >512 1 8 2 1 >512 16 16 256 4 
CFS0359 >512 1 1 512 1 >512 4 4 256 128 
CFS0360 >512 1 1 256 1 >512 4 4 256 128 
 
 
Table 2. Table summarising features extracted from the whole genome sequences of the E. 
coli collection. The MLST-associated sequence types; the corresponding phylogroup and 
serotypes; antimicrobial resistance genes organised by classes (determined also 
phenotypically in Figure 1); plasmid incompatibility types; S1 nuclease-PFGE plasmid 
profiles and genotypes associated with siderophores are included. Positive features are 
denoted using black squares; white squares indicate absence of marker. Incompatibility types 
were extracted from the PlasmidFinder 1.3 database. Siderophore sequences were extracted 
from virulence factor database (VFDB). 
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